Endometrial cancer gene panels: clinical diagnostic vs research germline DNA testing (Q30234614)

11 June 2017

title

Endometrial cancer gene panels: clinical diagnostic vs research germline DNA testing (English)

1 reference

11 June 2017

1 reference

Amanda B Spurdle

1 reference

11 June 2017

Michael A Bowman

1 reference

11 June 2017

Jannah Shamsani

series ordinal

1 reference

11 June 2017

Judy Kirk

series ordinal

1 reference

11 June 2017

publication date

28 April 2017

1 reference

11 June 2017

1 reference

Integrated genomic characterization of endometrial carcinoma

11 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Environmental (nongenetic) factors in gynecological cancers: update and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Family history and risk of endometrial cancer: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Genome-wide association study identifies a common variant associated with risk of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Five endometrial cancer risk loci identified through genome-wide association analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Gene-panel sequencing and the prediction of breast-cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

The landscape of microsatellite instability in colorectal and endometrial cancer genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Somatic mosaicism and double somatic hits can lead to MSI colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Lynch syndrome--related endometrial carcinomas show a high frequency of nonendometrioid types and of high FIGO grade endometrioid types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Cancer risks for MLH1 and MSH2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Risks of Lynch syndrome cancers for MSH6 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Polymerase ɛ (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Prognostic significance of POLE proofreading mutations in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Lifetime cancer risks in individuals with germline PTEN mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Endometrial cancer in a 15-year-old girl: A complication of Cowden Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Endometrial cancer in a 14-year-old girl with Cowden syndrome: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Germline PTEN, SDHB-D, and KLLN alterations in endometrial cancer patients with Cowden and Cowden-like syndromes: an international, multicenter, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Overview of the main outcomes in breast-cancer prevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Cancer Incidence in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Occult and subsequent cancer incidence following risk-reducing surgery in BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

BRCA1/2 germline mutations in Jewish patients with uterine serous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

The rate of the predominant Jewish mutations in the BRCA1, BRCA2, MSH2 and MSH6 genes in unselected Jewish endometrial cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Endometrium is not the primary site of origin of pelvic high-grade serous carcinoma in BRCA1 or BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Endometrial cancers in mutation carriers from hereditary breast ovarian cancer syndrome kindreds: report from the Creighton University Hereditary Cancer Registry with review of the implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Molecular characteristics of endometrial cancer coexisting with peritoneal malignant mesothelioma in Li-Fraumeni-like syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Li-Fraumeni syndrome: cancer risk assessment and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Diagnostic Performance of Whole-Body MRI as a Tool for Cancer Screening in Children With Genetic Cancer-Predisposing Conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

CHEK2 is a multiorgan cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

CHEK2 variant I157T may be associated with increased breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

The effect of CHEK2 variant I157T on cancer susceptibility: evidence from a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Increased Risk for Other Cancers in Addition to Breast Cancer for CHEK2*1100delC Heterozygotes Estimated From the Copenhagen General Population Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

CHEK2 I157T and endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Expanded extracolonic tumor spectrum in MUTYH-associated polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Genetic variants in MUTYH are not associated with endometrial cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Very high risk of cancer in familial Peutz-Jeghers syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependant destabilization of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Germline PIK3CA and AKT1 mutations in Cowden and Cowden-like syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Germline Heterozygous Variants in SEC23B Are Associated with Cowden Syndrome and Enriched in Apparently Sporadic Thyroid Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Reevaluation of RINT1 as a breast cancer predisposition gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Rare variants in the ATM gene and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Multigene testing of moderate-risk genes: be mindful of the missense

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Counselling framework for moderate-penetrance cancer-susceptibility mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Patterns and functional implications of rare germline variants across 12 cancer types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Multiplex Genetic Testing for Cancer Susceptibility: Out on the High Wire Without a Net?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

21 January 2018

Reply to J. Moline et al

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Evaluation of germline PTEN mutations in endometrial cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Colorectal cancer and theCHEK2 1100delC mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Germline mutation prevalence in the base excision repair gene,MYH, in patients with endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Endometrial cancer and somatic G>T KRAS transversion in patients with constitutional MUTYH biallelic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

Breast cancer risk in women with PALB2 mutations in different populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

7 January 2021

Environmental (nongenetic) factors in gynecological cancers: update and future perspectives

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

7 January 2021

Molecular mechanisms of tamoxifen-associated endometrial cancer (Review).

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

7 January 2021

Multigene panel testing: planning the next generation of research studies in clinical cancer genetics

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

7 January 2021

Pathologic features of endometrial carcinoma associated with HNPCC

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

7 January 2021

Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

7 January 2021

Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

7 January 2021

A mutation in POLE predisposing to a multi-tumour phenotype

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

7 January 2021

Endometrial Cancer in an Adolescent

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

7 January 2021

Breast cancer risk and clinical implications for germline PTEN mutation carriers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

7 January 2021

BRCA2 germline mutation in a woman with uterine serous papillary carcinoma--case report

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

7 January 2021

Effect of ATM, CHEK2 and ERBB2 TAGSNPs and haplotypes on endometrial cancer risk

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

7 January 2021

Hereditary gynecological tumors associated with Peutz-Jeghers syndrome (Review)

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

7 January 2021

[Systemic karyomegaly with chronic interstitial nephritis. Discussion of the disease picture based on an autopsy case]

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

7 January 2021

Extreme dysplasia in renal epithelium of a young woman dying from hepatocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2017.20

7 January 2021

Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing

1 reference

12 December 2020

GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer

1 reference

12 December 2020

Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management

1 reference

12 December 2020

High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice

1 reference

12 December 2020

Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families

1 reference

12 December 2020

CHEK2 mutations and HNPCC-related colorectal cancer.

1 reference

12 December 2020

BRCA germline mutations in women with uterine serous carcinoma--still a debate

1 reference

12 December 2020

CHEK2-mutation in Dutch breast cancer families: expanding genetic testing for breast cancer

1 reference

12 December 2020

Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.

1 reference

12 December 2020

Uncovering the role of p53 splice variants in human malignancy: a clinical perspective

1 reference

12 December 2020

10.1038/MODPATHOL.2017.20

Identifiers

DOI

1 reference

Dimensions Publication ID

11 June 2017

1085081610

0 references

1 reference